05/30/2026
We are pleased to announce that we have enrolled our first study subject in the OASIS OsteoAdapt™ SP FDA pivotal trial.
The procedure went extremely well, and we were able to achieve an excellent correction of the patient's coronal deformity. While surgical correction is important, the ultimate goal of spine surgery is not simply alignment on imaging. It is biological healing, successful fusion, and meaningful improvement in patient outcomes.
That is why studies like OASIS are so important. Through a rigorous FDA-regulated clinical trial, we will evaluate whether AMP-2 can enhance the biological processes necessary for successful spinal fusion and long-term patient recovery.
We are grateful to our research team, operating room staff, study sponsors, and most importantly, the patient who chose to participate in advancing the science of spine care.
We look forward to contributing to the evidence and sharing our experience as the study progresses.
Vail-Summit Orthopaedics & Neurosurgery Vail Health